Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714596 · ClinicalTrials.gov registry record · NA
Randomized Trial to Assess PO Versus IV Antibiotics
A NA study of Wound Infection, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- NA
- Development phase
- 233
- Enrollment target
- 20
- Study locations
NCT01714596: Completed NA study of Wound Infection, sponsored by Major Extremity Trauma Research Consortium.
NCT01714596 is a NA study of Wound Infection that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 233 participants, below the 355-participant average among 10 other Wound Infection trials with a reported enrollment target (34% lower). The trial reports 20 study locations across 17 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01714596, a NA study of Wound Infection, has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- NA
- Development phase
- 233 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this study is to evaluate the effect of treatment of post-op wound infection in long bones after fracture fixation or joint fusion and either: (Group 1) operative debridement and PO antibiotic treatment for 6 weeks; or (Group 2) operative debridement and IV antibiotics for 6 weeks. Primary Hypothesis 1: The rate of study injury related surgical interventions by one year in Group 1 will be non-inferior to the rate in Group 2. Secondary Hypothesis 1: The rate of treatment failure by one year in Group 1 will be non-inferior to the rate in Group 2. Treatment failure is defined as wound problems that require surgery \>2 weeks after initial debridement, infection recurrence, infection with a new pathogen, joint erosion, implant failure, medical problems related to the treatment administration which necessitates a switch from one arm to the other. Secondary Hypothesis 2: The rate of re-hospitalization for complications, infection, non-union and amputation by one year in Group 1 will be non-inferior to the rate in Group 2. Secondary Hypothesis 3: Following discharge for treatment of infection, per patient treatment costs at 1 year will be lower in Group 1 than in Group 2. Secondary Hypothesis 4: Adherence in Group 1 will be non-inferior to adherence in Group 2. Secondary Hypothesis 5: Patient satisfaction with treatment in Group 1 will be non-inferior to adherence in Group 2. Specific Aim 2: To build and validate a risk prediction model for failure of treatment of early post-op wound infections after fixation of fractures and joint fusions.
Conditions Studied
Interventions
- OTHER PO versus IV antibiotics Route of administration evaluation
Study Locations (20)
California
- Cedars Sinai Medical Center - Los Angeles
- University of California at San Francisco - San Francisco
New York
- Jamaica Hospital Medical Center - Jamaica
- NYU Langone Medical Center - New York
North Carolina
- Carolinas Medical Center - Charlotte
- Wake Forest Baptist Medical Center - Winston-Salem
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- Denver Health and Hospital Authority - Denver
Florida
- University of Miami Ryder Trauma Center - Miami
Indiana
- Eskenazi Health - Indianapolis
Iowa
- University of Iowa Hospitals & Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2013-12-03 |
| Est. Completion | 2020-12-30 |
| Phase | NA |
What the finished NCT01714596 record still lists
NCT01714596 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 355-participant average among 10 other Wound Infection trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Wound Infection appearing as the primary indexed condition, and to 1 intervention - of which PO versus IV antibiotics Route of administration evaluation is the first listed.
NCT01714596 names 20 study sites across 17 states, led by California, New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01714596 about?
NCT01714596 is a clinical study titled "Randomized Trial to Assess PO Versus IV Antibiotics". The goal of this study is to evaluate the effect of treatment of post-op wound infection in long bones after fracture fixation or joint fusion and either: (Group 1) operative debridement and PO antibiotic treatment for 6 weeks; or (Group 2) operative debridement and IV antibiotics for 6 weeks. Prim...
What is the current status of trial NCT01714596?
This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2013-12-03. Estimated completion is 2020-12-30.
What conditions does trial NCT01714596 study?
This clinical trial studies the following conditions: Wound Infection.
What interventions are being tested in trial NCT01714596?
The interventions under investigation include: PO versus IV antibiotics Route of administration evaluation (OTHER).
Who is sponsoring clinical trial NCT01714596?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01714596 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01714596's enrollment target sits among peer trials
233 5th of 10 higher than 6 of 10 other Wound Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Activated Carbon Interphase Effect on Biofilm and Total Bacterial Load
COMPLETED · NA
-
A Randomized Trial of Ostomy Closure Techniques
COMPLETED · NA
-
Tobramycin Injection to Prevent Infection in Open Fractures
ACTIVE NOT RECRUITING · Phase 3
-
Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation
COMPLETED · Phase 4
-
Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections
COMPLETED · Phase 1
-
A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI